Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-056072·Checkpoint Therapeutics, Inc.
Schedule 13D ownership disclosure
CHECKPOINT THERAPEUTICS INC
Common Stock, $0.0001 Par Value · CUSIP: 162828206
Event date: 2025-05-30
- Filing-level shares
- 0.00
- Percent of class
- 0%
- Fortress Biotech, Inc.Reported CIK 0001429260
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-056072
- Form type
- SCHEDULE 13D/A
- Filer
- Checkpoint Therapeutics, Inc.
- CIK
- CIK 1651407
- Filed
- Jun 03, 2025
- Reporting period
- May 30, 2025
- Description
- Schedule 13D beneficial ownership